Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine (CCJM)
In the absence of contraindications, metformin should be seriously considered as an off-label initial therapy and as an adjunct to antiobesity medications approved by the US Food and Drug Administration.
Endocrinology, Diabetes, Metabolism April 2nd 2025
Verywell Health
“It’s absolutely not nature’s Ozempic and does not work like Ozempic, which is a GLP-1 inhibitor. Manufacturers of these supplements are just kind of creating a hype…”
Clinical Pharmacology March 31st 2025
Journal of the Endocrine Society (JES)
Initial visit laboratory values, particularly HbA1C and 2-hour glucose, combined with BMI trajectory, offer more reliable predictive value for T2D progression than traditional fasting plasma glucose measurements.
Endocrinology, Diabetes, Metabolism January 30th 2025
Annals of Internal Medicine
Advanced molecular screening methods for colorectal cancer and AI-assisted colonoscopy detection systems represent significant developments in diagnostic technology, potentially improving both accuracy and accessibility of cancer screening programs.
Endocrinology, Diabetes, Metabolism January 7th 2025
SingleCare
Fresh pineapple demonstrates a moderate glycemic index of 51-66, making it a viable fruit option for diabetic patients when consumed with appropriate portion control and protein pairing strategies.
Endocrinology, Diabetes, Metabolism October 24th 2024
Healthline
The combination of structured lifestyle interventions with targeted pharmacotherapy demonstrates significant potential for achieving substantial weight loss in patients with type 2 diabetes.
Endocrinology, Diabetes, Metabolism October 22nd 2024